Cargando…

Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease

BACKGROUND: Retinal microvascular alterations have been previously described in Parkinson’s disease (PD) patients using optical coherence tomography angiography (OCT-A). However, an extensive description of retinal vascular morphological features, their association with PD-related clinical variables...

Descripción completa

Detalles Bibliográficos
Autores principales: Murueta-Goyena, Ane, Barrenechea, Maitane, Erramuzpe, Asier, Teijeira-Portas, Sara, Pengo, Marta, Ayala, Unai, Romero-Bascones, David, Acera, Marian, Del Pino, Rocío, Gómez-Esteban, Juan Carlos, Gabilondo, Iñigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311167/
https://www.ncbi.nlm.nih.gov/pubmed/34321998
http://dx.doi.org/10.3389/fnins.2021.708700
_version_ 1783728909231063040
author Murueta-Goyena, Ane
Barrenechea, Maitane
Erramuzpe, Asier
Teijeira-Portas, Sara
Pengo, Marta
Ayala, Unai
Romero-Bascones, David
Acera, Marian
Del Pino, Rocío
Gómez-Esteban, Juan Carlos
Gabilondo, Iñigo
author_facet Murueta-Goyena, Ane
Barrenechea, Maitane
Erramuzpe, Asier
Teijeira-Portas, Sara
Pengo, Marta
Ayala, Unai
Romero-Bascones, David
Acera, Marian
Del Pino, Rocío
Gómez-Esteban, Juan Carlos
Gabilondo, Iñigo
author_sort Murueta-Goyena, Ane
collection PubMed
description BACKGROUND: Retinal microvascular alterations have been previously described in Parkinson’s disease (PD) patients using optical coherence tomography angiography (OCT-A). However, an extensive description of retinal vascular morphological features, their association with PD-related clinical variables and their potential use as diagnostic biomarkers has not been explored. METHODS: We performed a cross-sectional study including 49 PD patients (87 eyes) and 40 controls (73 eyes). Retinal microvasculature was evaluated with Spectralis OCT-A and cognitive status with Montreal Cognitive Assessment. Unified PD Rating Scale and disease duration were recorded in patients. We extracted microvascular parameters from superficial and deep vascular plexuses of the macula, including the area and circularity of foveal avascular zone (FAZ), skeleton density, perfusion density, vessel perimeter index, vessel mean diameter, fractal dimension (FD) and lacunarity using Python and MATLAB. We compared the microvascular parameters between groups and explored their association with thickness of macular layers and clinical outcomes. Data were analyzed with General Estimating Equations (GEE) and adjusted for age, sex, and hypertension. Logistic regression GEE models were fitted to predict diagnosis of PD versus controls from microvascular, demographic, and clinical data. The discrimination ability of models was tested with receiver operating characteristic curves. RESULTS: FAZ area was significantly smaller in patients compared to controls in superficial and deep plexuses, whereas perfusion density, skeleton density, FD and lacunarity of capillaries were increased in the foveal zone of PD. In the parafovea, microvascular parameters of superficial plexus were associated with ganglion cell-inner plexiform layer thickness, but this was mainly driven by PD with mild cognitive impairment. No such associations were observed in controls. FAZ area was negatively associated with cognition in PD (non-adjusted models). Foveal lacunarity, combined with demographic and clinical confounding factors, yielded an outstanding diagnostic accuracy for discriminating PD patients from controls. CONCLUSION: Parkinson’s disease patients displayed foveal microvascular alterations causing an enlargement of the vascular bed surrounding FAZ. Parafoveal microvascular alterations were less pronounced but were related to inner retinal layer thinning. Retinal microvascular abnormalities helped discriminating PD from controls. All this supports OCT-A as a potential non-invasive biomarker to reveal vascular pathophysiology and improve diagnostic accuracy in PD.
format Online
Article
Text
id pubmed-8311167
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83111672021-07-27 Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease Murueta-Goyena, Ane Barrenechea, Maitane Erramuzpe, Asier Teijeira-Portas, Sara Pengo, Marta Ayala, Unai Romero-Bascones, David Acera, Marian Del Pino, Rocío Gómez-Esteban, Juan Carlos Gabilondo, Iñigo Front Neurosci Neuroscience BACKGROUND: Retinal microvascular alterations have been previously described in Parkinson’s disease (PD) patients using optical coherence tomography angiography (OCT-A). However, an extensive description of retinal vascular morphological features, their association with PD-related clinical variables and their potential use as diagnostic biomarkers has not been explored. METHODS: We performed a cross-sectional study including 49 PD patients (87 eyes) and 40 controls (73 eyes). Retinal microvasculature was evaluated with Spectralis OCT-A and cognitive status with Montreal Cognitive Assessment. Unified PD Rating Scale and disease duration were recorded in patients. We extracted microvascular parameters from superficial and deep vascular plexuses of the macula, including the area and circularity of foveal avascular zone (FAZ), skeleton density, perfusion density, vessel perimeter index, vessel mean diameter, fractal dimension (FD) and lacunarity using Python and MATLAB. We compared the microvascular parameters between groups and explored their association with thickness of macular layers and clinical outcomes. Data were analyzed with General Estimating Equations (GEE) and adjusted for age, sex, and hypertension. Logistic regression GEE models were fitted to predict diagnosis of PD versus controls from microvascular, demographic, and clinical data. The discrimination ability of models was tested with receiver operating characteristic curves. RESULTS: FAZ area was significantly smaller in patients compared to controls in superficial and deep plexuses, whereas perfusion density, skeleton density, FD and lacunarity of capillaries were increased in the foveal zone of PD. In the parafovea, microvascular parameters of superficial plexus were associated with ganglion cell-inner plexiform layer thickness, but this was mainly driven by PD with mild cognitive impairment. No such associations were observed in controls. FAZ area was negatively associated with cognition in PD (non-adjusted models). Foveal lacunarity, combined with demographic and clinical confounding factors, yielded an outstanding diagnostic accuracy for discriminating PD patients from controls. CONCLUSION: Parkinson’s disease patients displayed foveal microvascular alterations causing an enlargement of the vascular bed surrounding FAZ. Parafoveal microvascular alterations were less pronounced but were related to inner retinal layer thinning. Retinal microvascular abnormalities helped discriminating PD from controls. All this supports OCT-A as a potential non-invasive biomarker to reveal vascular pathophysiology and improve diagnostic accuracy in PD. Frontiers Media S.A. 2021-07-12 /pmc/articles/PMC8311167/ /pubmed/34321998 http://dx.doi.org/10.3389/fnins.2021.708700 Text en Copyright © 2021 Murueta-Goyena, Barrenechea, Erramuzpe, Teijeira-Portas, Pengo, Ayala, Romero-Bascones, Acera, Del Pino, Gómez-Esteban and Gabilondo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Murueta-Goyena, Ane
Barrenechea, Maitane
Erramuzpe, Asier
Teijeira-Portas, Sara
Pengo, Marta
Ayala, Unai
Romero-Bascones, David
Acera, Marian
Del Pino, Rocío
Gómez-Esteban, Juan Carlos
Gabilondo, Iñigo
Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title_full Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title_fullStr Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title_full_unstemmed Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title_short Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease
title_sort foveal remodeling of retinal microvasculature in parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311167/
https://www.ncbi.nlm.nih.gov/pubmed/34321998
http://dx.doi.org/10.3389/fnins.2021.708700
work_keys_str_mv AT muruetagoyenaane fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT barrenecheamaitane fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT erramuzpeasier fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT teijeiraportassara fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT pengomarta fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT ayalaunai fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT romerobasconesdavid fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT aceramarian fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT delpinorocio fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT gomezestebanjuancarlos fovealremodelingofretinalmicrovasculatureinparkinsonsdisease
AT gabilondoinigo fovealremodelingofretinalmicrovasculatureinparkinsonsdisease